Cuong Ha, MD
Dermatology · Gainesville, VANPI 1962499061
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $271 of the $371 with a category attached, or 73.1%. 7 manufacturers reported payments, led by AbbVie at 30.6% of the total. Reporting peaked in 2023 at $147 and has fallen 88.7% since, to $17 in 2025. That places this record below the midpoint for dermatology clinicians in VA, where the typical reported total is $1,785.
Across 15 payments — averaging $24.75 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$114
- E.r. Squibb & Sons, L.L.C.$100
- Galderma Laboratories, L.p.$62
- Arcutis Biotherapeutics, Inc.$30
- Lilly USA, LLC$28
- Sun Pharmaceutical Industries Inc.$24
- plus $14 from 1 others
What the payments were for
- Food & beverage$27173%
- Education$10027%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 6 | $114 |
| E.r. Squibb & Sons, L.L.C. | 1 | $100 |
| Galderma Laboratories, L.p. | 3 | $62 |
| Arcutis Biotherapeutics, Inc. | 2 | $30 |
| Lilly USA, LLC | 1 | $28 |
| Sun Pharmaceutical Industries Inc. | 1 | $24 |
| Johnson & Johnson | 1 | $14 |
How this compares
$371 in reported general payments places this provider in the 20th percentile of 396 dermatology providers in Virginia.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Doxycycline Ir-DrDoxycycline Monohydrate | 12 | $4,700 |
| Clobetasol Propionate | 31 | $3,377 |
| Fluorouracil | 38 | $2,717 |
| Ketoconazole | 74 | $1,622 |
| Fluocinonide | 37 | $1,553 |
| Metronidazole | 31 | $1,392 |
| Azelaic Acid | 12 | $1,352 |
| Alclometasone Dipropionate | 25 | $894 |
| Doxycycline Hyclate | 17 | $773 |
| Triamcinolone Acetonide | 136 | $673 |
| Clindamycin Phosphate | 13 | $519 |
| Minocycline Hcl | 21 | $421 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Gainesville
- Naiem IssaVienna$2M
- Saurabh SinghFairfax$1.7M
- Diego DasilvaVirginia Beach$1.1M
- Vishal PatelLeesburg$719K
- Cyndi Torosky TommasoVirginia Beach$717K
- Daniel HurdBlacksburg$545K
- Jonathan SchreiberNorfolk$330K
- Robert BaerSuffolk$303K
- David PariserNorfolk$261K
- Hema SundaramFairfax$181K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.